Background: Genome-wide association studies (GWAS) have identified hundreds of loci 39
Short abstract
We propose a network-based, conditional approach for genome-wide analysis of multivariate 65 omics phenotypes. Our methods can incorporate prior biological knowledge about biological 66 pathways from external sources. We evaluated our approach using metabolomics data and 67 demonstrated that our approach has bigger power and allows for identification of additional loci. 68 We show that gain in power is achieved through increased precision of genetic effect estimates, 69 and in presence of specific 'contra-intuitive' pleiotropic scenarios (when genetic and 70 environmental sources of covariance are acting in opposite manner). We justify existence of such 71 scenarios, and discuss possible applications of our method beyond metabolomics. Conventional univariate GWAS (uGWAS) ignore dependencies between different omics traits, 90 which confounds biological interpretation of results and may lead to loss of statistical power. It 91 was shown that utilizing multivariate phenotype representation increases statistical power, and 92 leads to richer findings in the association tests compared to the univariate analysis [4] [5] [6] [7] . Despite 93 large number of methodological works, only few empirical multivariate GWAS have been 94 published for humans. Among these which should be noted in relation to our work, Inouye et al. 95 [8] performed multivariate GWAS of 130 NMR metabolites (grouped in 11 sets) in ~6600 96 individuals. The study demonstrated that multivariate analysis doubles the number of loci detected 97 in this sample; among loci discovered via multivariate analysis seven were novel and did not 98 appear before in other GWAS of related traits. While no replication of novel loci was performed 99 in the original study, we compared results reported by Inouye et al. with recently published 100 univariate GWAS of NMR metabolomics, which used sample size of up to 24,925 individuals [9] . 101
We found that for three out of seven SNPs reported in the original work, p-value was < 5x10 -11 for 102 at least one metabolite. This provides empirical evidence for the value of multivariate methods in 103 genomics of metabolic traits. 104
Here we propose a (knowledge-based) network-driven conditional genome-wide 105 association analysis that exploits information from biologically related traits. To demonstrate our 106 methodology, we performed proof-of-principle study directly comparing the power of univariate 107 GWAS and the proposed method using metabolomics data (151 metabolites, Biocrates assay) from 108 the KORA F4 study (n=1785 Mendelian randomization analysis is interpreted as the effect of the covariate on the trait free of 131 non-genetic confounders [10] . Note that while * is reflecting the covariance between the trait 132 and the covariate, which is induced by the effect of the genotype, is related to 'purely 133 environmental' sources of covariance between y and c. We can conclude that when genotype-134 induced and environmental correlations are consistent in sign, the product * is positive and 135 hence the contribution of the second term of (1) into relative power is negative. On the contrary, a 136 'surprising' product (where the sign is inconsistent and hence * is negative) contribute 137 positively to the relative power of conditional model. 138
In the context of complex polygenic traits, one expects that genetic and environmental 139 correlations are consistent in sign. This is well reflected in animal breeding literature, and for a 140 recent human example, one can see [11] . Under this scenario it would be desirable that (effect 141 of genotype onto covariate) is very small, while (which makes contribution into reduction of 142 2 compared to 2 ) is large. However, in the context of specific locus affecting an activity of an 143 enzyme involved in a biochemical reaction, the 'surprising' inconsistency between and * 144 may be not so surprising. Indeed, consider an allele, which is associated with increased activity of 145 an enzyme converting substrate A into product B. It is expected that A and B are positively 146 correlated, and that the allele is in positive correlation with level of product B and in negative 147 correlation with the substrate A. This is exactly a scenario which would lead to the positive value 148 of the second term in (1), hence providing additional increase in power on the top of noise 149 reduction. 150
We can readily extend the formula (1) to a case when k covariates are included in the 151 conditional model. Denoting coefficients of correlation between g and covariate i as and partial 152 coefficients of regression of y onto covariate i as , we have 153
Above considerations allow us to hypothesize that a conditional GWAS (cGWAS), where 155 covariates selected are biochemical, one-reaction-step neighbors of the target trait may provide 156 increased power by exploiting both noise reduction and possible 'surprising' pleiotropy. In this 157 work, we set off to empirically verify this hypothesis by investigating of human metabolomics 158 data. 159
When proper covariates are selected, the methodology of cGWAS using individual-level 160 data becomes rather trivial, and boils down to running a GWAS in which one jointly estimates the 161 effect of an SNP and of specific covariates. The cGWAS method is less trivial in case one would 162 like to exploit summary-level univariate GWAS data, for example these data which are available 163 from previously published studies. Formulation of cGWAS on the level of summary GWAS 164 statistics is possible, and we describe this method in Supplementary Note 1. 165
The question of selection of proper covariates is very important because it has direct consequences 166 on the chances of finding the 'surprising' pleiotropic scenarios. In case biological/biochemical 167 relations between the traits of interest are known and summarized in some database(s), this 168 knowledge can be used directly by e.g. taking all direct neighbors as covariates. Alternatively, the 169 network may be reconstructed in a hypothesis-free, empirical manner from the same or external 170 data by e.g. using Gaussian graphical models (GGM) approach [12] ; then some threshold may be 171 applied to select the covariates. 172
173

Comparison between cGWAS and uGWAS using human metabolomics data 174
We compared cGWAS and uGWAS methods using individual-level genetic and metabolomics 175 data from KORA F4 study (1,784 individuals measured for 151 metabolite, Biocrates assay, and 176 imputed at 1,717,498 SNPs). 177
First, we explored the potential of cGWAS where covariates were selected based on known 178 biochemical network. Thus our analysis was restricted to a subset of 105 metabolites for which the 179 one-reaction-step immediate biochemical neighbors were available [12] . This biochemical 180 network incorporates only lipid metabolites, and pathway reactions cover two groups of pathways: 181
(1) Fatty acid biosynthesis reactions which apply to the metabolite classes lyso-PC, diacyl-PC, 182
acyl-alkyl-PC and sphingomyelins; (2) β-oxidation reactions representing fatty acid degradation 183 to model reactions between the acyl-carnitines. The β-oxidation model consists of a linear chain 184 of C2 degradation steps (C10-C8-C6 etc.). Number of covariates varied from one to four with 185 mean of 2.48 and median 2. 186 Table 1 shows 11 loci which were significant in either cGWAS or uGWAS analysis and 187 fall into known regions (see Supplementary Note 2). Of these, ten loci were identifiable by 188 cGWAS and nine were identifiable by uGWAS. Compared to uGWAS, one locus (ETFDH) was 189 lost, but two additional loci were identified (ACSL1 for PC ae C42:5, and PKD2L1 for 190 lysoPC a C16:1). It is interesting to note that for ACSL1 (SNP rs4862429 effect onto PC ae C42:5, 191 with cGWAS p=7e-11), the uGWAS p-value was 0.7. This is expected under the model of 192
To test whether use of cGWAS increases average power of association analysis, we 194 contrasted the average of cGWAS and uGWAS maximal chi-squared test statistics for loci from 195 For the SNPs listed in Table 1 , we applied formula (2) to partition the log-ratio of the 199 cGWAS and uGWAS test statistics into 'noise' and 'pleiotropic' components. Figure 1 shows that 200 the trend in the ratio is mainly determined by the second ('pleiotropic') summand. One can see 201 that, with the exception of locus SLC22A4, SNP-trait pairs for which cGWAS had increased power 202 are these where the second term of (1) is positive or close to zero. In contrast, the SNP-trait 203 combinations which were lost in cGWAS, had strong negative contribution from the 'pleiotropic' 204 term of (2). 205
It is interesting to investigate the variance-covariance structure of loci with positive and 206 negative pleiotropic term. We selected two loci where the pleiotropic component's contribution to 207 power was positive (rs174547 at FADS1 locus) and negative (rs8396 at ETFDH). We show 208 corresponding correlations between SNP and trait and covariates involved, together with partial 209 coefficients from conditional regression of the trait onto SNP and covariates in Figure 2 . For 210 FADS1 locus (Figure 2A) , the correlation between SNP and the trait (lysoPC a C20:4) and the 211 covariate (lysoPC a C20:3) are in opposite directions, while the trait and the covariate are 212 positively correlated (both based on correlation and partial correlation). As a consequence, we can 213 see that the value of partial regression coefficient between the SNP and lysoPC a C20:4, 214 conditional on lysoPC a C20:3 is greater than coefficient of regression without covariates. This 215 makes biological sense as FADS1 is coding the fatty acid desaturase enzyme, while these two traits 216 differ from each other by one double bond. It appears that this case suits perfectly the biochemical 217 scenario under which we expect increased power of conditional analysis. 218
In the second example ( Figure 2B , ETFDH), we observe that conditional regression of C10 219 onto rs8396 and two covariates (C8 and C12, medium-chain acylcarnitines) leads to smaller SNP 220 coefficient compared to unconditional regression; this happens because all terms of 221
/ are positive. The ETFDH gene, prioritised as the best candidate by DEPICT 222 (FDR<5%), encodes for electron transfer flavoprotein dehydrogenase that is involved into fatty 223 acid oxidation in the mitochondria. During this process the acyl group is transferred from long 224 chain acylcarnitines to form long-chain acetyl-CoA, which is then catabolized. ETF 225 dehydrogenase takes part in the catabolic process by transferring electrons from Acyl-CoA 226 dehydrogenase into the oxidative phosphorylation pathway. Thus, the ETFDH gene should act on 227 all kinds of long-chain acylcarnitines in the same direction and we can expect that pleotropic 228 influence of this gene onto the acylcarnitines in our example (C8, C10, C12) will be unidirectional. 229
Presence unidirectional genetic effects and positive correlations between these acylcarnitines 230 makes second term of equation (2) negative, which leads to the decreased power of genetic 231 association analysis. 232
Above analysis provide a real-life example that use of biochemical neighbors to adjust 233 genetic association analysis of target trait allows for (sometimes very sharp) increase of power for 234 the genetic variants which act in 'surprising' pleiotropic manner; our analysis also suggests that 235 cGWAS may increase GWAS power on average, although this increase is not uniform and heavily 236 depends on pleiotropic relations between involved locus and the traits. 237
While use of known biochemical network for covariate selection has many attractive 238 properties, it may be somewhat unpractical, because our biochemical knowledge is yet fragmented. 239
Therefore, next we have investigated the potential of cGWAS method where covariates are 240 selected using data-driven approach. The metabolites network was reconstructed using Gaussian 241
Graphical Models based on partial correlations. For a target metabolite, covariates were selected 242 based on significant partial correlations. For that, we have chosen threshold proposed previously 243 in [12]: p-value<(0.01/Number of calculated partial correlations), which corresponds to a cut-off 244 p-value<8.83x10 -7 . The network used in our analysis is presented in Supplementary Figure 1 . 245 For the clarity of notation, hereafter we will call cGWAS using known biochemical network as 246 BN-cGWAS, and cGWAS which is based on GGM selection of covariates as GGM-cGWAS. Table  264 1. We found 16 SNP-trait pairs clustered to 10 loci that could be detected by GGM-cGWAS or 265 BN-cGWAS. The number of covariates included into GGM-cGWAS analysis, was larger (from 2 266 to 18, with mean of 8.5) than that in BN-cGWAS. Therefore, we expected that GGM-cGWAS 267 may gain relative power compared to BN-cGWAS because of noise reduction (term 1 of equation 268 (2)); however, we it may also be expected that GGM-cGWAS may lose power because of less 269 likely occurrence of 'surprise' pleiotropy (term 2 of equation (2)). 270
For the best SNP-trait pairs detected by GGM-cGWAS or BN-cGWAS, we computed the 271 components of equation (2) and contrasted them using Wilcoxon paired samples test. The noise 272 component of (2) was always greater for GGM-cGWAS (mean difference of 0.66, p=3x10 -5 ). For 273 GGM-cGWAS, the second 'pleiotropic' component of equation (2) was on average smaller than 274 that for the BN-cGWAS (mean difference -0.54, p=0.013); still, for three GGM-cGWAS SNP-275 trait pairs out of 16 the pleiotropic component was positive. Average Chi-squared statistics was 276 33% smaller for GGM-cGWAS that for BN-cGWAS indicating average loss of power (although 277 this loss was not significant, Wilcoxon paired test p=0.5), but at the same time it still was 22% 278 bigger than uGWAS (Wilcoxon paired test p=0.8). We conclude that while GGM-cGWAS is in a 279 way imperfect proxy to use of real biochemical network, it may still have increased power because 280 of even further reduced target trait residual variance, and some potential to detect 'surprising' 281 pleiotropy. 282
To explore the potential of cGWAS under realistic conditions to a full extent, we analyzed 283 all 151 available metabolites using GGM-cGWAS and contrasted the results to uGWAS ( Table 2  284 and Supplementary Figure 2) . In total, uGWAS was able to detect 15 loci at genome-wide 285 significance level defined as p<5x10 -8 /151 = 3.3x10 -10 . Applying GGM-cGWAS, we identified 19 286 significant loci at the same threshold. Expectedly, we observed that compared to uGWAS the 287 precision of genetic effect estimation increased (Table 2, Supplementary Figure 3) . The overlap 288 between uGWAS and GGM-cGWAS findings was 14 loci, with GGM-cGWAS losing one locus 289 (for C5:1-DC at rs2943644), but identifying five new loci not identified by uGWAS. Three of the 290 five new loci were affecting amino acids, and two -acylcarnitines. Note that loci identified by 291 BN-cGWAS (covariates selected via biochemical network) are a subset of 19 loci identified by 292
GGM-cGWAS. 293
We have investigated the literature results available for the loci described in We have developed a new approach for network-based conditional genome-wide association study 325 for metabolomics data (conditional GWAS, cGWAS). For each metabolite trait, we select a set of 326 other metabolites, to be used as covariates in GWAS. The selection of covariates could be done in 327 a mechanistic way, e.g. based on known biological relations between traits of interest; or in a data-328 driven way, e.g. based on partial correlations. The method has modest computational costs and can 329 exploit either individual-or summary-level GWAS data. It has a potential to increase the power 330 of genetic association analysis because of reduced noise and ability to detect specific pleiotropic 331 scenarios, hardly detectable via standard single-trait GWAS. 332
We have applied cGWAS approach to analysis of 151 metabolomics traits (Biocrates 333 panel) in large (n=1,784) population-based KORA cohort. While conventional uGWAS identified 334 15 loci in this data set, cGWAS was able to identify up to 5 additional loci. At the same time, we 335 have observed that for some loci the power of cGWAS was decreased. We found that in cGWAS 336 power is always gained because of increased precision of genetic effect estimation, but it may be 337 decreased or increased in presence of specific pleiotropic association scenarios. 338
We show that conditional analysis has especially high power under scenarios when locus-339 specific genotypic and environmental sources of covariance between the trait and its covariates 340 are 'surprising' (acting in opposite direction). This type of pleiotropy is not unexpected for 341 metabolic traits, and we provide an empirical demonstration of existence of such scenarios in this 342
work. This is further demonstrated by the fact that the power gain from the pleiotropic component 343 was higher when we used a mechanistic way of covariate selection (one-reaction-step neighbors 344 from a biochemical network), as opposed to data-driven network (based on Gaussian Graphical 345 Model). We may expect that with increased knowledge of biological networks the mechanistic 346 way of covariate selection may become preferable. Chamber (Bayerische Landesärztekammer), and all participants gave written informed consent. 369
Concentrations of 163 metabolites were quantified in 3,061 serum samples of KORA F4 370 participants using flow injection electrospray ionization tandem mass spectrometry and the 371 AbsoluteIDQ TM p150 Kit (BIOCRATES Life Sciences AG, Innsbruck, Austria) [21] . After quality 372 control 151 metabolite measurements were used in analysis. Details of the methods and quality 373 control of the metabolite measurements and details of the metabolite nomenclatures were given 374 previously [21] . Metabolite nomenclatures could be found in Supplementary Table 3 . (1,717,498 SNPs in total) were considered in analysis. The genomic control method was applied 390 to correct for a possible inflation of the test statistics. Lambda for all traits was between 1.00 and 391 1.03. To define independent loci, we have selected all genome-wide significant SNP-trait pairs, 392
and identified the groups which were separated by >500kb. For regions of association, the most 393 associated SNP-trait pair (as indicated by the lowest p-value) was selected to represent this locus. 
